Upgrade to SI Premium - Free Trial

Solid Biosciences (SLDB)

8.33 +1.02 (13.95%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: SMITH IAN F June 11, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: Freed Martin I June 11, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: Nagendran Sukumar June 11, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: EDELMAN JOSEPH June 11, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: Ganot Ilan June 11, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: Keresty Georgia June 11, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: Sullivan Lynne Marie June 11, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: Kahn Clare June 11, 2026 4:05 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: Stone Adam Leo June 11, 2026 4:05 PM - SEC Filing Form 8-K Solid Biosciences Inc. For: Jun 10 June 10, 2026 4:05 PM - SEC Filing Form 424B7 Solid Biosciences Inc. June 5, 2026 4:04 PM - SEC Filing Solid Biosciences (SLDB) PT Raised to $25 at H.C. Wainwright June 3, 2026 6:49 AM - StreetInsider Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 1, 2026 4:05 PM - StreetInsider Solid Biosciences to Participate at Upcoming Investor Conferences June 1, 2026 8:00 AM - StreetInsider Solid Biosciences (SLDB) PT Lowered to $11 at JPMorgan May 19, 2026 7:34 AM - StreetInsider Solid Biosciences (SLDB) PT Lowered to $16 at Wedbush May 13, 2026 8:31 AM - StreetInsider Solid Biosciences (SLDB) PT Raised to $18 at Piper Sandler May 13, 2026 7:22 AM - StreetInsider Solid Biosciences (SLDB) Misses Q1 EPS by 52c May 12, 2026 5:09 PM - StreetInsider Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates May 12, 2026 4:08 PM - Globe NewsWire Form 10-Q Solid Biosciences Inc. For: Mar 31 May 12, 2026 4:03 PM - SEC Filing Solid Biosciences begins phase 3 trial for Duchenne therapy SGT-003 May 7, 2026 8:00 AM - StreetInsider Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy May 7, 2026 8:00 AM - Globe NewsWire Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: Invus Global Management, LLC May 5, 2026 9:42 AM - SEC Filing Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 1, 2026 4:05 PM - StreetInsider Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy April 30, 2026 8:00 AM - Globe NewsWire Solid Biosciences receives European orphan drug designation for SGT-003 April 28, 2026 8:02 AM - StreetInsider Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy April 28, 2026 8:01 AM - Globe NewsWire Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: BlackRock, Inc. April 27, 2026 4:14 PM - SEC Filing Form ARS Solid Biosciences Inc. For: Dec 31 April 23, 2026 7:09 PM - SEC Filing Form DEFA14A Solid Biosciences Inc. April 23, 2026 7:09 PM - SEC Filing Form DEF 14A Solid Biosciences Inc. For: Jun 10 April 23, 2026 7:08 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Brooks Gabriel April 21, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Cumbo Alexander April 21, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Tan Kevin April 21, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Herzich Paul April 21, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Howton David T April 21, 2026 4:06 PM - SEC Filing Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Hanrahan Jessie April 21, 2026 4:05 PM - SEC Filing Form PRE 14A Solid Biosciences Inc. For: Jun 10 April 10, 2026 4:12 PM - SEC Filing Form 8-K Solid Biosciences Inc. For: Apr 10 April 10, 2026 4:10 PM - SEC Filing Solid Biosciences to Participate at Upcoming Investor Conferences April 7, 2026 12:35 PM - Globe NewsWire Solid Biosciences to Participate at Upcoming Investor Conferences April 7, 2026 8:14 AM - StreetInsider Form 4 Solid Biosciences Inc. For: Apr 02 Filed by: SMITH IAN F April 2, 2026 4:06 PM - SEC Filing Form EFFECT Solid Biosciences Inc. April 1, 2026 6:07 AM - SEC Filing Form EFFECT Solid Biosciences Inc. April 1, 2026 6:07 AM - SEC Filing Solid Biosciences (SLDB) PT Raised to $12 at JPMorgan March 25, 2026 8:40 AM - StreetInsider Guggenheim Starts Solid Biosciences (SLDB) at Buy March 20, 2026 6:08 AM - StreetInsider Full Article List